Copyright © Inderes 2011 - present. All rights reserved.
Log in to receive notifications.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

BICO Group AB (publ) has repurchased convertible bonds to a total nominal amount of SEK 118m

22.11.2024, 18.00
BICO Group

On March 19, 2021, BICO Group AB (publ) (“BICO” or the “Company”) issued senior unsecured convertible bonds with a total nominal amount of SEK 1,500,000,000 (the “Convertible Bonds”).

On November 22, 2024, the Company repurchased Convertible Bonds with a total nominal amount of SEK 118,000,000 at a purchase price of 83.63 percent (excluding accrued but unpaid interest) of the Convertible Bond’s nominal amount. The total purchase consideration for the bought-back Convertible Bonds thereby amounted to SEK 98,682,500 (the “Buyback”). Following the Buyback, BICO’s holdings of the Convertible Bonds totals a nominal amount of SEK 118,000,000.

The rationale behind the Buyback was to optimize BICO’s capital structure and made possible by the Company’s strong liquidity position. BICO will continue to evaluate the bond market and may from time to time repurchase further Convertible Bonds in the market, subject to the liquidity needs of the Company.

Carnegie Investment Bank AB (publ) acted as Dealer Manager in the Buyback.

For further information, please contact:
Jacob Thordenberg, CFO, BICO Group AB
Phone: +46 735 34 88 84
E-mail: jt@bico.com

The information was submitted for publication, through the agency of the contact person set out above, on November 22, 2024 at 6pm CET.

BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 46,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 12,000 publications. Operating through three business areas – Lab Automation, Life Science Solutions, and Bioprinting – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com

Attachments
BICO Group AB (publ) has repurchased convertible bonds to a total nominal amount of SEK 118m

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.